Loading...
SeaStar Medical Holding Corporation
ICU•NASDAQ
Healthcare
Biotechnology
$0.43
$0.00(0.00%)
SeaStar Medical Holding Corporation (ICU) Financial Performance & Statements
Review SeaStar Medical Holding Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-25.56%
↓ 25.56%
Net Income Growth
5.34%
↑ 5.34%
Operating Cash Flow Growth
-55.63%
↓ 55.63%
Operating Margin
-4138.79%
↓ 4138.79%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-3716.12%
↓ 3716.12%
ROE
601.84%
↑ 601.84%
ROIC
-3135.22%
↓ 3135.22%
SeaStar Medical Holding Corporation (ICU) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for SeaStar Medical Holding Corporation stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $135000.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $135000.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $1.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $9.11M | $5.97M | $2.82M | $2.77M |
| SG&A Expenses | $8.87M | $8.04M | $6.60M | $1.68M |
| Operating Expenses | $17.98M | $14.21M | $11.61M | $4.45M |
| Total Costs & Expenses | $17.98M | $14.21M | $11.61M | $4.45M |
| Interest Income | $101000.00 | $0.00 | $630.00 | $212.00 |
| Interest Expense | $244000.00 | $1.08M | $630000.00 | $212000.00 |
| Depreciation & Amortization | $0.00 | $14.01M | $11.61M | $4.45M |
| EBITDA | -$24.58M | -$11.14M | -$11.61M | $0.00 |
| EBITDA Ratio | -$182.10 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$17.84M | -$14.21M | -$11.61M | -$4.45M |
| Operating Income Ratio | -$132.16 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$6.99M | -$12.02M | -$11.40M | -$148000.00 |
| Income Before Tax | -$24.83M | -$26.23M | -$23.01M | -$4.60M |
| Income Before Tax Ratio | -$183.90 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $3000.00 | $0.00 | $1000.00 | -$1000.00 |
| Net Income | -$24.83M | -$26.23M | -$23.01M | -$4.60M |
| Net Income Ratio | -$183.93 | $0.00 | $0.00 | $0.00 |
| EPS | -$5.05 | -$30.29 | -$70.16 | -$15.90 |
| Diluted EPS | -$5.05 | -$30.26 | -$70.07 | -$15.87 |
| Weighted Avg Shares Outstanding | $3.74M | $866000.00 | $328000.00 | $289000.00 |
| Weighted Avg Shares Outstanding (Diluted) | $3.74M | $866813.00 | $328450.00 | $289551.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan